Literature DB >> 7862928

Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice.

M Hiramatsu1, H Satoh, T Kameyama, T Nabeshima.   

Abstract

The effects of nicotine on carbon monoxide (CO)-induced amnesia in mice were investigated using a step-down type passive avoidance task. Mice were exposed to CO 3 times at 1-h intervals, 7 days before the first training and retention test and 24 h after the first training session. Memory deficiency occurred in mice when training commenced more than 3 days after CO exposure (delayed amnesia): the median step-down latency in the retention test of the CO-exposed group was significantly shorter than that of the control group. Administration of (-)-nicotine (15.6 and 31.3 nmol/kg, IP) 15 min before the first training session prolonged the step-down latency in the CO-exposed group, but (+)-nicotine did not. To determine whether this effect of (-)-nicotine was mediated via nicotinic cholinergic receptors, we attempted to block its action using a nicotinic acetylcholine receptor antagonist (mecamylamine). Mecamylamine (1.25 mumol/kg) blocked the effect of (-)-nicotine (31.3 nmol/kg) on delayed amnesia. Administration of (-)-nicotine (15.6-62.5 nmol/kg) immediately after the first training session failed to ameliorate learning ability in the CO-exposed group. These results suggest that (-)-nicotine potentiates the nicotinic cholinergic neuronal system and may potentiate acquisition of memory.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862928     DOI: 10.1007/bf02244868

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats.

Authors:  M W Decker; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  The effects of cholinergic drugs and cholinergic-rich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats.

Authors:  H Hodges; Y Allen; J Sinden; S N Mitchell; T Arendt; P L Lantos; J A Gray
Journal:  Behav Brain Res       Date:  1991-04-18       Impact factor: 3.332

3.  Drugs as research tools in psychology: cholinergic drugs and information processing.

Authors:  D M Warburton; K Wesnes
Journal:  Neuropsychobiology       Date:  1984       Impact factor: 2.328

Review 4.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

5.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Interactive effects of physical work and carbon monoxide on cognitive task performance.

Authors:  D E Bunnell; S M Horvath
Journal:  Aviat Space Environ Med       Date:  1988-12

7.  Some central effects in mice of compounds related to nicotine.

Authors:  R B Barlow; A Oliverio; M Satta; G M Thompson
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

Review 8.  Catecholamines and aversive learning: a review.

Authors:  T P Oei; M G King
Journal:  Neurosci Biobehav Rev       Date:  1980       Impact factor: 8.989

9.  Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.

Authors:  E D Levin; C Lee; J E Rose; A Reyes; G Ellison; M Jarvik; E Gritz
Journal:  Behav Neural Biol       Date:  1990-03

10.  Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions.

Authors:  B R Martin; H L Tripathi; M D Aceto; E L May
Journal:  J Pharmacol Exp Ther       Date:  1983-07       Impact factor: 4.030

View more
  2 in total

1.  In Response to: "Single Versus Multiple Hyperbaric Sessions for Carbon Monoxide Poisoning in a Murine Model".

Authors:  Leah S Croll; Rachel S Wightman; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2016-10-04

Review 2.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.